Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.8166
+0.0436 (5.64%)
At close: Aug 13, 2025, 4:00 PM
0.8170
+0.0004 (0.05%)
Pre-market: Aug 14, 2025, 8:44 AM EDT
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
n/a
Profits / Employee
-$2,675,111
Market Cap
36.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ITRM News
- 8 days ago - Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 16 days ago - Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 - GlobeNewsWire
- 6 weeks ago - Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - GlobeNewsWire
- 7 weeks ago - Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence - GlobeNewsWire
- 2 months ago - Iterum Therapeutics Announces Partnership for Commercialization Services - GlobeNewsWire
- 3 months ago - Iterum Therapeutics Announces Extension of Term of Promissory Note - GlobeNewsWire